UC85:LSE:LSE-UBS Barclays US Liquid Corporates UCITS hedged (GBX)

ETF | Others |

Last Closing

USD 1386.75

Change

-0.50 (-0.04)%

Market Cap

USD 0.12B

Volume

607.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-02 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XNIF:LSE Xtrackers Nifty 50 Swap UCITS ..

+72.50 (+0.36%)

USD 292,109.69B
XNID:LSE Xtrackers Nifty 50 Swap UCITS ..

+1.91 (+0.73%)

USD 292,109.69B
0R1O:LSE Amazon.com Inc.

+0.20 (+0.10%)

USD 1,607.29B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

-0.10 (-0.58%)

USD 701.81B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

-0.12 (-0.84%)

USD 636.56B
0R1I:LSE NVIDIA Corp.

-0.48 (-0.43%)

USD 618.20B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
0QZK:LSE Coca-Cola Co.

+0.15 (+0.21%)

USD 266.08B
PRJU:LSE Amundi Index Solutions - Amund..

-0.16 (-0.54%)

USD 259.48B
0QZO:LSE 0QZO

-0.05 (-0.05%)

USD 258.54B

ETFs Containing UC85:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 0.27% 52% F 54% F
Dividend Return 0.02% 36% F 40% F
Total Return 0.29% 50% F 53% F
Trailing 12 Months  
Capital Gain 1.02% 37% F 47% F
Dividend Return 0.04% 30% F 26% F
Total Return 1.06% 32% F 44% F
Trailing 5 Years  
Capital Gain -15.62% 12% F 22% F
Dividend Return 0.15% 17% F 24% F
Total Return -15.47% 10% F 20% F
Average Annual (5 Year Horizon)  
Capital Gain -5.48% 8% B- 19% F
Dividend Return -5.48% 7% C- 18% F
Total Return 0.00% 19% F 12% F
Risk Return Profile  
Volatility (Standard Deviation) 7.90% 74% C 86% B+
Risk Adjusted Return -69.27% 5% F 9% A-
Market Capitalization 0.12B 52% F 29% F

Annual Financials (GBX)

Quarterly Financials (GBX)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.